BMO Capital Markets Issues Positive Forecast for Extendicare (TSE:EXE) Stock Price

Extendicare (TSE:EXEGet Free Report) had its price target lifted by investment analysts at BMO Capital Markets from C$24.00 to C$30.00 in a research report issued on Monday,BayStreet.CA reports. BMO Capital Markets’ price objective would indicate a potential upside of 12.28% from the company’s current price.

Several other research analysts have also weighed in on the company. TD Securities increased their price objective on Extendicare from C$15.00 to C$19.00 in a research report on Thursday, November 13th. Canaccord Genuity Group upped their price target on Extendicare from C$20.00 to C$22.50 in a research note on Thursday, December 4th. Cormark raised their price objective on Extendicare from C$25.00 to C$30.00 in a research report on Wednesday, December 3rd. Canadian Imperial Bank of Commerce boosted their price objective on shares of Extendicare from C$18.00 to C$22.00 in a report on Thursday, November 13th. Finally, National Bank Financial upped their target price on shares of Extendicare from C$24.50 to C$29.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, Extendicare presently has a consensus rating of “Buy” and an average price target of C$25.36.

View Our Latest Stock Report on EXE

Extendicare Trading Up 0.5%

Extendicare stock traded up C$0.14 during midday trading on Monday, hitting C$26.72. 261,013 shares of the stock were exchanged, compared to its average volume of 320,571. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The stock’s 50-day simple moving average is C$23.08 and its 200 day simple moving average is C$18.80. Extendicare has a fifty-two week low of C$12.12 and a fifty-two week high of C$27.44. The stock has a market capitalization of C$2.52 billion, a price-to-earnings ratio of 25.21 and a beta of 1.30.

Extendicare (TSE:EXEGet Free Report) last posted its quarterly earnings results on Thursday, February 26th. The company reported C$0.29 earnings per share for the quarter. The business had revenue of C$462.03 million during the quarter. Extendicare had a net margin of 4.48% and a return on equity of 64.13%. On average, equities analysts anticipate that Extendicare will post 0.6134729 EPS for the current year.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Read More

Analyst Recommendations for Extendicare (TSE:EXE)

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.